Regeneron is a scientist’s drug company. Founded by a pair of them in 1988, they run the biotech in a way that employees say sets it apart from big pharma. “The focus is not on the bottom line but on the patient,” says one. Of particular pride: Regeneron’s commitment to R&D and its “endless [drug] pipeline.” Read Great Place to Work review here.
Company Info
Rank last year | 85 |
Years on list | 4 |
HQ location | Tarrytown, N.Y. |
Employees | 6323 |
Job openings (as of February 2018) | 534 |
Industry | Biotechnology & Pharmaceuticals |
Revenue, 2017 or most recent year ($M) | $4,860 |
Year founded | 1988 |
Type of organization | Public |
Number of work sites | 3 |
Website | http://www.regeneron.com |
Perks
100% health coverage | no |
Unlimited sick days | no |
Telecommuting | no |
Job sharing | no |
Subsidized childcare | - |
Compressed work weeks | no |
Fully-paid sabbaticals | no |
On-site fitness/subsidized gym | yes |
On-site medical care facility | no |
Non-discrimination policy includes sexual orientation | yes |
Health insurance for part-timers | no |
Sick days for part-timers | no |
College tuition reimbursement | yes |
Student loan debt repayment | no |
Medical facility at all locations | no |
Diversity
% Minorities | - |
% African-American/Black | - |
% Asian | - |
% Caucasian/White | - |
% Hispanic/Latino | - |
% Native American/Alaska Native | - |
% Native Hawaiian/Pacific Islander | - |
% Two or more races | - |
% Unknown ethnicity | - |
Paid Time Off
General PTO | 34 |
# Sick days | - |
General PTO for part-timers | - |
# Sick days for part-timers | - |
Compensation
Most common job (for salaried employee) | Research Associates |
Avg. base pay (salaried) | - |
Avg. extra compensation (salaried) | - |
Total pay for most common job (salaried) | - |
Hiring/Staffing (Past 12 Months)
Full-time and part-time job growth | 14% |
# of job applicants | 96,000 |
Avg. # of applicants per opening | 46 |
FT voluntary turnover | - |
Jobs filled internally | 18% |
Jobs filled by referral | 31% |
# New graduates hired | 350 |